Cargando…
Medication Related Osteonecrosis of the Jaw: 2021 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons
Antiresorptives are the most widely prescribed drugs for the treatment of osteoporosis. They are also used in malignant bone metastases, multiple myeloma, and Paget’s disease, and provide therapeutic efficacy on those diseases. However, it was reported that the occurrence of osteonecrosis of the jaw...
Autores principales: | Kim, Jin-Woo, Kwak, Mi Kyung, Han, Jeong Joon, Lee, Sung-Tak, Kim, Ha Young, Kim, Se Hwa, Jung, Junho, Lee, Jeong Keun, Lee, Young-Kyun, Kwon, Yong-Dae, Kim, Deog-Yoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Bone and Mineral Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671025/ https://www.ncbi.nlm.nih.gov/pubmed/34905675 http://dx.doi.org/10.11005/jbm.2021.28.4.279 |
Ejemplares similares
-
Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons
por: Kim, Kyoung Min, et al.
Publicado: (2015) -
Author’s reply to the letter to the editor of Journal of the Korean Association of Oral and Maxillofacial Surgeons
por: Lee, Jeong-Keun
Publicado: (2023) -
Journal of the Korean Association of Oral and Maxillofacial Surgeons is continuously improving its quality level
por: Kim, Young-Kyun
Publicado: (2019) -
Expert opinion about osteonecrosis of the jaw
por: Lee, Jeong Keun
Publicado: (2017) -
The Korean Cough Guideline: Recommendation and Summary Statement
por: Rhee, Chin Kook, et al.
Publicado: (2016)